Cellemedy
Gyeonggi-do, South Korea · Founded 2016
- Headquarters
- Gyeonggi-do
- Founded
- 2016
- Business Model
- B2B
- Website
- cellemedy.com
About
Cellemedy is a biotechnology company developing next-generation therapeutic modalities intended to replace conventional antibody treatments. Its official company page describes the work as therapeutic-protein development, and its location page lists the company at Healthcare Innovation Park in Seongnam, South Korea. The company positions its research around alternatives to established antibody-based approaches, rather than as a general-purpose life-sciences services provider.
Summary
Cellemedy is a Biotech company based in Gyeonggi-do, South Korea, founded in 2016.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
Specialty pharmaceutical company focused on addressing therapeutic needs in the fields of psychia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/cellemedy"><img src="https://indexed.vc/api/badge/company/cellemedy" alt="Cellemedy on Indexed.vc" width="260" height="76" /></a>